Embleema
The company provides a no-code platform that unifies multimodal patient data, including genomic, clinical, and self-reported data, for Phase IV and non-interventional research. Its software serves life science sponsors and clinical sites by automating data capture from electronic health records, wearables, and patient-reported outcomes to generate regulatory-grade real-world evidence. The system includes a consent-driven data sharing module and patient-facing apps to maintain longitudinal engagement for long-term studies.
Funding summary
- Total raised
- €3.2M
- Funding rounds
- 1
Investors in Embleema
Investors on record for Embleema. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Embleema?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors